Lung cancer represents one of the top malignancies in cancer-related incidence and mortality worldwide. Throughout the years, efforts have been made to develop new therapeutic options that can provide an improved quality of life and […]
Researches indicated that gastric cancer is the fifth most prevalent cancer globally and has the third-highest mortality rate among all cancers. Thus, it is imperative to explore biomarkers to assess patients’ prognoses and provide possible […]
Esophageal squamous cell carcinoma (ESCC) is one of the main types of esophageal cancer (EC), accounting for more than 90% of patients with EC in China. Although the treatment has been improved in recent years, […]
Hepatocellular carcinoma (HCC) is a highly malignant tumor. Previous studies have shown that lots of genes are involved in the development of HCC and may be used as prognostic biomarkers of HCC. However, there are […]
Kaposi sarcoma (KS) is a rare disease, and there is no specific treatment protocol agreed upon, especially for the classical type. Chemotherapeutics such as paclitaxel, pegylated liposomal doxorubicin (PLD), etoposide, gemcitabine are used in the […]
The group of authors from Affiliated Zhongda Hospital of Southeast University performed a study on the upper tract urothelial carcinoma. In their study, the authors sought to explore the incidence trends of upper tract urothelial […]
Background The research on the molecular pathology of pancreatic cancer (PCC) has not been in-depth enough, and there is a lack of comprehensive analysis of the transcriptomics and clinical characteristics of the disease to determine […]
Cancer is a condition in which the cells in a specific part of the body grow and reproduce uncontrollably. The cancerous cells can invade and destroy surrounding healthy tissue, including organs. Furthermore, cancer is among […]
An accurate preoperative diagnosis of parotid tumors is essential for selection and planning of the surgical treatment, used in the most cases of parotid tumors. Many previous studies have shown that the modern cross-sectional imaging […]
Background Renal cell carcinoma (RCC) represents the 15th most common cancer worldwide. About 20% of patients with renal cell carcinoma eventually develop liver metastasis (LM). Furthermore, the liver is the only site of distant spread […]
Copyright (c) 2021 Association of Basic Medical Sciences of FBIH